The Impact of Pharmaceutical Innovation on Longevity and Medical Expenditure in Sweden, 1997-2010: Evidence from Longitudinal, Disease-Level Data
Author
Abstract
Suggested Citation
Download full text from publisher
Other versions of this item:
- Frank R. Lichtenberg & Billie Pettersson, 2014. "The impact of pharmaceutical innovation on longevity and medical expenditure in Sweden, 1997-2010: evidence from longitudinal, disease-level data," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 23(3), pages 239-273, April.
References listed on IDEAS
- Lichtenberg Frank R., 2010.
"Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A Reexamination Using Data from the U.S. and Australia,"
Forum for Health Economics & Policy, De Gruyter, vol. 13(2), pages 1-18, August.
- Frank R. Lichtenberg, 2010. "Are Increasing 5-Year Survival Rates Evidence of Success Against Cancer? A reexamination using data from the U.S. and Australia," NBER Working Papers 16051, National Bureau of Economic Research, Inc.
- G. M.P. Swann, 2009. "The Economics of Innovation," Books, Edward Elgar Publishing, number 13211.
- Gene M. Grossman & Elhanan Helpman, 1991.
"Quality Ladders in the Theory of Growth,"
The Review of Economic Studies, Review of Economic Studies Ltd, vol. 58(1), pages 43-61.
- Gene M. Grossman & Elhanan Helpman, 1989. "Quality Ladders in the Theory of Growth," NBER Working Papers 3099, National Bureau of Economic Research, Inc.
- Grossman, G.M. & Helpman, E., 1989. "Quality Ledders In The Theory Of Growth," Papers 148, Princeton, Woodrow Wilson School - Public and International Affairs.
- Lichtenberg Frank R., 2013.
"The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996–2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files,"
Forum for Health Economics & Policy, De Gruyter, vol. 16(1), pages 1-33, January.
- Frank R. Lichtenberg, 2012. "The Effect of Pharmaceutical Innovation on Longevity: Patient-Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-Use Files," NBER Working Papers 18552, National Bureau of Economic Research, Inc.
- Lichtenberg, Frank R., 2013.
"The impact of therapeutic procedure innovation on hospital patient longevity: Evidence from Western Australia, 2000–2007,"
Social Science & Medicine, Elsevier, vol. 77(C), pages 50-59.
- Frank R. Lichtenberg, 2011. "The Impact of Therapeutic Procedure Innovation on Hospital Patient Longevity: Evidence from Western Australia, 2000-2007," NBER Working Papers 17414, National Bureau of Economic Research, Inc.
- Frank Lichtenberg, 2009. "The effect of new cancer drug approvals on the life expectancy of American cancer patients, 1978-2004," Economics of Innovation and New Technology, Taylor & Francis Journals, vol. 18(5), pages 407-428.
- Kevin M. Murphy & Robert H. Topel, 2006.
"The Value of Health and Longevity,"
Journal of Political Economy, University of Chicago Press, vol. 114(5), pages 871-904, October.
- Kevin M. Murphy & Robert H. Topel, 2005. "The Value of Health and Longevity," NBER Working Papers 11405, National Bureau of Economic Research, Inc.
- Productivity Commission, 2005. "Impacts of Advances in Medical Technology in Australia," Research Reports, Productivity Commission, Government of Australia, number 17.
- Frank Lichtenberg, 2012. "Contribution of Pharmaceutical Innovation to Longevity Growth in Germany and France, 2001–7," PharmacoEconomics, Springer, vol. 30(3), pages 197-211, March.
Citations
Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
Cited by:
- Huarng, Kun-Huang & Yu, Tiffany Hui-Kuang, 2015. "Healthcare expenditure with causal recipes," Journal of Business Research, Elsevier, vol. 68(7), pages 1570-1573.
- Frank R. Lichtenberg, 2014. "The Impact of Pharmaceutical Innovation on Disability Days and the Use of Medical Services in the United States, 1997-2010," Journal of Human Capital, University of Chicago Press, vol. 8(4), pages 432-480.
- Nishimura, Junichi & Nagaoka, Sadao & Yoneyama-Hirozane, Mariko, 2022. "The impact of science-intensive drugs on longevity and cure rate: Evidence from new prescription drugs launched in Japan," Journal of the Japanese and International Economies, Elsevier, vol. 64(C).
Most related items
These are the items that most often cite the same works as this one and are cited by the same works as this one.- Frank R. Lichtenberg, 2015.
"Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010,"
International Journal of the Economics of Business, Taylor & Francis Journals, vol. 22(2), pages 277-299, July.
- Frank Lichtenberg, 2015. "Pharmaceutical Innovation, Longevity, and Medical Expenditure in Greece, 1995-2010," CESifo Working Paper Series 5166, CESifo.
- Lichtenberg, Frank R., 2014. "The impact of pharmaceutical innovation on longevity and medical expenditure in France, 2000–2009," Economics & Human Biology, Elsevier, vol. 13(C), pages 107-127.
- Lichtenberg, Frank R. & Tatar, Mehtap & Çalışkan, Zafer, 2014. "The effect of pharmaceutical innovation on longevity, hospitalization and medical expenditure in Turkey, 1999–2010," Health Policy, Elsevier, vol. 117(3), pages 361-373.
- Frank R. Lichtenberg, 2014.
"Has Medical Innovation Reduced Cancer Mortality?,"
CESifo Economic Studies, CESifo Group, vol. 60(1), pages 135-177.
- Frank R. Lichtenberg, 2010. "Has medical innovation reduced cancer mortality?," NBER Working Papers 15880, National Bureau of Economic Research, Inc.
- Frank R. Lichtenberg, 2017. "The Impact of Pharmaceutical Innovation on Premature Mortality, Hospital Separations, and Cancer Survival in Australia," The Economic Record, The Economic Society of Australia, vol. 93(302), pages 353-378, September.
- Nishimura, Junichi & Nagaoka, Sadao & Yoneyama-Hirozane, Mariko, 2022. "The impact of science-intensive drugs on longevity and cure rate: Evidence from new prescription drugs launched in Japan," Journal of the Japanese and International Economies, Elsevier, vol. 64(C).
- Hostenkamp, Gisela & Lichtenberg, Frank R., 2015.
"The impact of recent chemotherapy innovation on the longevity of myeloma patients: US and international evidence,"
Social Science & Medicine, Elsevier, vol. 130(C), pages 162-171.
- Frank Lichtenberg & Gisela Hostenkamp, 2013. "The Impact of Recent Chemotherapy Innovation on the Longevity of Myeloma Patients: U.S. and International Evidence," CESifo Working Paper Series 4516, CESifo.
- Chu, Angus C. & Pan, Shiyuan, 2013.
"The Escape-Infringement Effect Of Blocking Patents On Innovation And Economic Growth,"
Macroeconomic Dynamics, Cambridge University Press, vol. 17(4), pages 955-969, June.
- Chu, Angus C. & Pan, Shiyuan, 2010. "The Escape-Infringement Effect of Blocking Patents on Innovation and Economic Growth," MPRA Paper 27233, University Library of Munich, Germany.
- Aghion, Philippe & Akcigit, Ufuk & Howitt, Peter, 2014.
"What Do We Learn From Schumpeterian Growth Theory?,"
Handbook of Economic Growth, in: Philippe Aghion & Steven Durlauf (ed.), Handbook of Economic Growth, edition 1, volume 2, chapter 0, pages 515-563,
Elsevier.
- Philippe Aghion & Ufuk Akcigit & Peter Howitt, 2013. "What Do We Learn From Schumpeterian Growth Theory?," NBER Working Papers 18824, National Bureau of Economic Research, Inc.
- Aghion, Philippe & Akcigit, Ufuk & Howitt, Peter, 2013. "What Do We Learn From Schumpeterian Growth Theory?," Working Paper Series in Economics and Institutions of Innovation 298, Royal Institute of Technology, CESIS - Centre of Excellence for Science and Innovation Studies.
- Philippe Aghion & Ufuk Akcigit & Peter Brown, 2013. "What Do We Learn From Schumpeterian Growth Theory?," PIER Working Paper Archive 13-026, Penn Institute for Economic Research, Department of Economics, University of Pennsylvania.
- Aghion, Philippe & Akcigit, Ufuk & Howitt, Peter, 2013. "What Do We Learn From Schumpeterian Growth Theory?," Scholarly Articles 27755233, Harvard University Department of Economics.
- Eric Budish & Benjamin Roin & Heidi Williams, 2013. "Do fixed patent terms distort innovation? Evidence from cancer clinical trials," Discussion Papers 13-001, Stanford Institute for Economic Policy Research.
- Jeon, Heesang, 2015. "Knowledge and Contemporary Capitalism in Light of Marx's Value Theory," Thesis Commons g5njk, Center for Open Science.
- Ufuk Akcigit & Salomé Baslandze & Francesca Lotti, 2023.
"Connecting to Power: Political Connections, Innovation, and Firm Dynamics,"
Econometrica, Econometric Society, vol. 91(2), pages 529-564, March.
- Ufuk Akcigit & Salomé Baslandze & Francesca Lotti, 2018. "Connecting to Power: Political Connections, Innovation, and Firm Dynamics," NBER Working Papers 25136, National Bureau of Economic Research, Inc.
- Ufuk Akcigit & Salomé Baslandze & Francesca Lotti, 2022. "Connecting to power: political connections, innovation, and firm dynamics," Temi di discussione (Economic working papers) 1376, Bank of Italy, Economic Research and International Relations Area.
- Ufuk Akcigit & Salomé Baslandze & Francesca Lotti, 2020. "Connecting to Power: Political Connections, Innovation, and Firm Dynamics," FRB Atlanta Working Paper 2020-5, Federal Reserve Bank of Atlanta.
- Akcigit, Ufuk & Baslandze, Salomé & Lotti, Francesca, 2018. "Connecting to Power: Political Connections, Innovation, and Firm Dynamics," CEPR Discussion Papers 13216, C.E.P.R. Discussion Papers.
- Hélène Latzer & Kiminori Matsuyama & Mathieu Parenti, 2018.
"The market Size Effect in Endogenous Growth Reconsidered,"
Documents de travail du Centre d'Economie de la Sorbonne
18032, Université Panthéon-Sorbonne (Paris 1), Centre d'Economie de la Sorbonne.
- Hélène Latzer & Kiminori Matsuyama & Mathieu Parenti, 2018. "The Market Size Effect in Endogenous Growth Reconsidered," Post-Print halshs-01901266, HAL.
- Hélène Latzer & Kiminori Matsuyama & Mathieu Parenti, 2018. "The Market Size Effect in Endogenous Growth Reconsidered," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-01901266, HAL.
- Carlino, Gerald & Kerr, William R., 2015.
"Agglomeration and Innovation,"
Handbook of Regional and Urban Economics, in: Gilles Duranton & J. V. Henderson & William C. Strange (ed.), Handbook of Regional and Urban Economics, edition 1, volume 5, chapter 0, pages 349-404,
Elsevier.
- Gerald Carlino & William R. Kerr, 2014. "Agglomeration and Innovation," Harvard Business School Working Papers 15-007, Harvard Business School.
- Carlino, Gerald & Kerr, William R., 2015. "Agglomeration and innovation," Bank of Finland Research Discussion Papers 27/2015, Bank of Finland.
- Gerald Carlino & William R. Kerr, 2014. "Agglomeration and Innovation," NBER Working Papers 20367, National Bureau of Economic Research, Inc.
- Gerald A. Carlino & William R. Kerr, 2014. "Agglomeration and innovation," Working Papers 14-26, Federal Reserve Bank of Philadelphia.
- Guido Cozzi & Silvia Galli, 2014.
"Sequential R&D and blocking patents in the dynamics of growth,"
Journal of Economic Growth, Springer, vol. 19(2), pages 183-219, June.
- Guido Cozzi & Silvia Galli, 2012. "Sequential R&D and Blocking Patents in the Dynamics of Growth," Working Papers 2012_02, Durham University Business School.
- Cozzi, Guido & Galli, Silvia, 2013. "Sequential R&D and Blocking Patents in the Dynamics of Growth," Economics Working Paper Series 1305, University of St. Gallen, School of Economics and Political Science.
- Janger, Jürgen & Schubert, Torben & Andries, Petra & Rammer, Christian & Hoskens, Machteld, 2017.
"The EU 2020 innovation indicator: A step forward in measuring innovation outputs and outcomes?,"
Research Policy, Elsevier, vol. 46(1), pages 30-42.
- Jürgen Janger & Torben Schubert & Petra Andries & Christian Rammer & Machteld Hoskens, 2016. "The EU 2020 Innovation Indicator. A Step Forward in Measuring Innovation Outputs and Outcomes?," WIFO Working Papers 529, WIFO.
- Janger, Jürgen & Schubert, Torben & Andries, Petra & Rammer, Christian & Hoskens, Machteld, 2016. "The EU 2020 innovation indicator: A step forward in measuring innovation outputs and outcomes?," ZEW Discussion Papers 16-072, ZEW - Leibniz Centre for European Economic Research.
- Ronald Goettler & Brett Gordon, 2014. "Competition and product innovation in dynamic oligopoly," Quantitative Marketing and Economics (QME), Springer, vol. 12(1), pages 1-42, March.
- Valentina Bosetti & Cristina Cattaneo & Elena Verdolini, 2012.
"Migration, Cultural Diversity and Innovation: A European Perspective,"
Working Papers
2012.69, Fondazione Eni Enrico Mattei.
- Bosetti, Valentina & Cattaneo, Cristina & Verdolini, Elena, 2012. "Migration, Cultural Diversity and Innovation: A European Perspective," Economy and Society 138634, Fondazione Eni Enrico Mattei (FEEM).
- Valentina Bosetti & Cristina Cattaneo & Elena Verdolini, 2012. "Migration, Cultural Diversity and Innovation: A European Perspective," Working Papers 469, IGIER (Innocenzo Gasparini Institute for Economic Research), Bocconi University.
- Gray, Elie & Grimaud, André, 2014. "The Lindahl equilibrium in Schumpeterian growth models: Knowledge diffusion, social value of innovations and optimal R&D incentives," TSE Working Papers 14-469, Toulouse School of Economics (TSE).
- Kyle, Margaret & Dubois, Pierre, 2016. "The Effects of Pharmaceutical Innovation on Cancer Mortality," CEPR Discussion Papers 11487, C.E.P.R. Discussion Papers.
More about this item
Keywords
longevity; pharmaceutical; innovation; drugs; Sweden;All these keywords.
JEL classification:
- I12 - Health, Education, and Welfare - - Health - - - Health Behavior
- J11 - Labor and Demographic Economics - - Demographic Economics - - - Demographic Trends, Macroeconomic Effects, and Forecasts
- L65 - Industrial Organization - - Industry Studies: Manufacturing - - - Chemicals; Rubber; Drugs; Biotechnology; Plastics
- O33 - Economic Development, Innovation, Technological Change, and Growth - - Innovation; Research and Development; Technological Change; Intellectual Property Rights - - - Technological Change: Choices and Consequences; Diffusion Processes
Statistics
Access and download statisticsCorrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:ces:ceswps:_3894. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Klaus Wohlrabe (email available below). General contact details of provider: https://edirc.repec.org/data/cesifde.html .
Please note that corrections may take a couple of weeks to filter through the various RePEc services.